Payne; Aimee S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Payne; Aimee S..The latest application filed is for "compositions and methods of acetylcholine receptor chimeric autoantibody receptor cells".

Company Profile

10.8.15

Payne; Aimee S. - Merion Station PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and methods of chimeric autoantibody receptor T cells Grant 11,407,804 - Payne , et al. August 9, 2	2022-08-09
Compositions and methods of chimeric autoantibody receptor T cells Grant 11,407,802 - Payne , et al. August 9, 2	2022-08-09
Compositions and methods of chimeric autoantibody receptor T cells Grant 11,407,803 - Payne , et al. August 9, 2	2022-08-09
Compositions And Methods Of Acetylcholine Receptor Chimeric Autoantibody Receptor Cells App 20220242931 - PAYNE; Aimee S. ; et al.	2022-08-04
Compositions And Methods Of Phospholipase A2 Receptor Chimeric Autoantibody Receptor T Cells App 20220098271 - Gill; Saar ; et al.	2022-03-31
Compositions And Methods For Treating Melanoma With A Chimeric Antigen Receptor App 20210161958 - Ridky; Todd ; et al.	2021-06-03
Compositions And Methods Of Phospholipase A2 Receptor Chimeric Autoantibody Receptor T Cells App 20210095001 - Gill; Saar ; et al.	2021-04-01
Method of Redirecting T Cells to Treat HIV Infection App 20200362012 - Riley; James L. ; et al.	2020-11-19
Compositions And Methods For Targeting Gamma Delta T Cells With Chimeric Antigen Receptors App 20200339687 - Payne; Aimee S. ; et al.	2020-10-29
Method of redirecting T cells to treat HIV infection Grant 10,738,099 - Riley , et al. A	2020-08-11
Compositions And Methods Of Muscle Specific Kinase Chimeric Autoantibody Receptor Cells App 20190375817 - Payne; Aimee S. ; et al.	2019-12-12
Compositions And Methods Of Chimeric Autoantibody Receptor T Cells App 20190315831 - PAYNE; Aimee S. ; et al.	2019-10-17
Compositions And Methods Of Chimeric Autoantibody Receptor T Cells App 20190315830 - PAYNE; Aimee S. ; et al.	2019-10-17
Compositions And Methods Of Chimeric Autoantibody Receptor T Cells App 20190315829 - Payne; Aimee S. ; et al.	2019-10-17
Compositions And Methods Of Chimeric Autoantibody Receptor T Cells App 20190309041 - PAYNE; Aimee S. ; et al.	2019-10-10
Compositions and methods of chimeric autoantibody receptor T cells Grant 10,301,370 - Payne , et al.	2019-05-28
Method of Redirecting T Cells to Treat HIV Infection App 20180265565 - Riley; James L. ; et al.	2018-09-20
Compositions And Methods Of Chimeric Autoantibody Receptor T Cells App 20170051035 - PAYNE; Aimee S. ; et al.	2017-02-23
Isolation of anti-desmoglein 1 antibodies by phage display of pemphigus foliaceus autoantibodies Grant 8,846,867 - Payne , et al. September 30, 2	2014-09-30
Anti-autoimmune antibodies for treatment of pemphigus Grant 8,298,545 - Payne , et al. October 30, 2	2012-10-30
Isolation of Anti-Desmoglein 1 Antibodies by Phage Display of Pemphigus Foliaceus Autoantibodies App 20110091449 - Payne; Aimee S. ; et al.	2011-04-21
Anti-Autoimmune Antibodies for Treatment of Pemphigus App 20100135948 - Payne; Aimee S. ; et al.	2010-06-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.